C. Ann Merrifield, Director at Lyra Therapeutics, Inc. (LYRA), bought 3,500 shares at $8.97 ($31K) on 2021-06-17, disclosed to the SEC on 2021-06-22.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| Filing → |
| FLXN | BUY | 2019-05-24 | $101K | — | Filing → |
| JNP | BUY | 2016-08-29 | $11K | — | Filing → |
| FLXN | BUY | 2016-06-16 | $13K | — | Filing → |